What's new

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised

Feb 11, 2025 - 14:17
 0
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Minutes of the COMP meeting 3-5 December 2024

Next Article

Payment issues in south India’s cotton yarn; fabric demand offers hope

Related Posts

Paediatric investigation plans: questions and answers

Paediatric investigation plans: questions and answers

Mar 24, 2025  0

EMEA-001716-PIP07-22

EMEA-001716-PIP07-22

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): mResvia, Single-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0